Fairprice Medsurge Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 14-12-2024
- Paid Up Capital ₹ 0.10 M
as on 14-12-2024
- Company Age 12 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2022)
- Profit -1393.63%
(FY 2022)
- Ebitda -1393.63%
(FY 2022)
- Net Worth -296.40%
(FY 2022)
- Total Assets -79.62%
(FY 2022)
About Fairprice Medsurge
The Corporate was formerly known as Mg Surgicals Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Tiwari Jatasankar and Shivam Tiwari serve as directors at the Company.
- CIN/LLPIN
U33110GJ2012PTC071144
- Company No.
071144
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Jul 2012
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Fairprice Medsurge?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Tiwari Jatasankar  | Director | 01-Sep-2021 | Current |
| Shivam Tiwari | Additional Director | 08-Dec-2021 | Current |
Financial Performance of Fairprice Medsurge.
Fairprice Medsurge Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 1393.63% decrease in profit. The company's net worth observed a substantial decline by a decrease of 296.4%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Fairprice Medsurge?
In 2022, Fairprice Medsurge had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Ratannabha Enterprise Private LimitedActive 3 years 29 days
Tiwari Jatasankar and Shivam Tiwari are mutual person
- Storks Healthcare Private LimitedActive 6 months 27 days
Tiwari Jatasankar and Shivam Tiwari are mutual person
- Devi Chamunda Multiservices Private LimitedActive 2 years 5 months
Tiwari Jatasankar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Fairprice Medsurge?
Unlock and access historical data on people associated with Fairprice Medsurge, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Fairprice Medsurge, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Fairprice Medsurge's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
